Previous 10 | Next 10 |
home / stock / mkkgy / mkkgy news
2023-09-20 14:02:43 ET Summary Exscientia plc has partnered with Merck KGaA for AI-powered drug discovery in complex disease segments, solidifying its industry positioning. AI is gaining traction in the healthcare industry, with projections estimating the AI drug discovery market ...
2023-09-20 07:47:47 ET More on Exscientia and AI drug discovery Seeking Alpha’s Quant Rating on Exscientia Exscientia Is Worth The AI-Driven Speculation Exscientia gains as enrollments begin for cancer trial AI to represent 11% of healthcare budgets in...
2023-08-13 11:40:00 ET Summary Merck KGaA reported disappointing Q2 results with a decrease in gross profit and EBIT compared to the previous year. The company remains confident in its 2025 targets despite reducing its full-year guidance for 2023. Anticipated double-digit reve...
2023-08-05 07:21:02 ET Merck KGaA (MKGAF) Q2 2023 Earnings Conference Call August 3, 2023 8:00 a.m. ET Company Participants Constantin Fest - Head of Investor Relations Belén Garijo - Chief Executive Officer Helene von Roeder - Chief Financial Officer Ma...
2023-07-26 15:04:29 ET The World Health Organization updated its Essential Medicines List on Wednesday without adding a class of weight loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists as a treatment for obesity. The list designed to guide state procurement deci...
Data Vault Holdings, Inc. and p-Chip Corporation to Connect Platforms through Enabling IP Licensing Agreement PR Newswire Microtransponder Technology Adds to Web 3.0 Anchor Options and a Host of Capabilities to DataVault's Data Management Platform NEW YOR...
2023-07-16 20:14:12 ET UK-based HSBC initiated coverage of 19 major biopharma stocks this past week, labeling Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ), Merck KGaA ( OTCPK:MKGAF ) ( OTCPK:MKKGY ) and Lonza ( OTCPK:LZAGY ) ( OTCPK:LZAGF ) as potential comeback stories, wh...
Athinia™ expands partnerships to include Tokyo Electron for real-time collaborative analytics of semiconductor fab equipment performance PR Newswire Athinia ™ platform enables limitless analytics capabilities, including sophisticated AI and machin...
2023-05-26 14:01:57 ET Oncolytics Biotech ( NASDAQ: ONCY ) shed ~16% on Friday after announcing results from its Phase 2 trial for experimental therapy pelareorep as a combination regimen in patients with a certain type of breast cancer. Results shared ahead of a presentatio...
2023-05-25 19:36:30 ET Summary It is expected that the market opportunity for disease-modifying therapies for MS will reach $29.8 billion in 2030; further projected that OCREVUS could generate sales of $6.3 billion by 2030. Roche Holding AG reported positive results reported from ...
News, Short Squeeze, Breakout and More Instantly...
Merck KGaA ADR Company Name:
MKKGY Stock Symbol:
OTCMKTS Market:
Data Vault Holdings, Inc. and p-Chip Corporation to Connect Platforms through Enabling IP Licensing Agreement PR Newswire Microtransponder Technology Adds to Web 3.0 Anchor Options and a Host of Capabilities to DataVault's Data Management Platform NEW YOR...
Athinia™ expands partnerships to include Tokyo Electron for real-time collaborative analytics of semiconductor fab equipment performance PR Newswire Athinia ™ platform enables limitless analytics capabilities, including sophisticated AI and machin...
Micron to Select Athinia™ for Pioneering Data Collaboration PR Newswire A long-term, strategic, enterprise-level technology collaboration aims to further increase production efficiencies and reduce costs for Micron and its suppliers CAMBRIDGE, Mass...